Current management of anal canal cancer

Current Oncology Reports

Volumn 11, Issue 3, 2009, Pages 186-192

  Czito, Brian G ^a   Willett, Christopher G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; MITOMYCIN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ANUS CANCER; BLOOD TOXICITY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSIMETRY; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKOPENIA; LUNG TOXICITY; MORBIDITY; NEPHROTOXICITY; NEUTROPENIA; POSITRON EMISSION TOMOGRAPHY; RADIATION MONITORING; RECTUM ABDOMINOPERINEAL RESECTION; REVIEW; SEPSIS; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; MITOMYCIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 65349138179     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0027-1     Document Type: Review

References (24)

1. Boman BM, Moertel CG, O'Connell MJ, et al.: Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984, 54: 114-125.
2. Nigro ND, Vaitkevicius VK, Considine B Jr: Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 1974, 17: 354-356.
3. Buroker TR, Nigro N, Bradley G, et al.: Combined therapy for cancer of the anal canal: A follow-up report. Dis Colon Rectum 1977, 20: 677-678.
4. Michaelson RA, Magill GB, Quan SH, et al.: Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer 1983, 51: 390-395.
5. Nigro ND, Seydel HG, Considine B, et al.: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983, 51: 1826-1829.
6. Leichman L, Nigro N, Vaitkevicius VK, et al.: Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Am J Med 1985, 78: 211-215.
7. Meeker WR Jr, Sickle-Santanello BJ, Philpott G, et al.: Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 1986, 57: 525-529.
8. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 1996, 348: 1049-1054.
9. Bartelink H, Roelofsen F, Eschwege F, et al.: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15: 2040-2049.
10. Flam M, John M, Pajak T, et al.: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996, 14: 2527-2539.
11. Ajani J, Winter K, Gunderson L, et al.: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. A randomized controlled trial. JAMA 2008, 299: 1914-1921.
12. Ajani J, Winter KA Gunderson L, et al.: Intergroup RTOG 98-11: a phase III randomized study of 5-fluoruracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal [abstract]. J Clin Oncol 2006, 24: 180s.
13. Gunderson LL, Winter K, Ajani J, et al.: Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin vs 5-FU and cisplatin for anal canal carcinoma: Impact of disease-free, overall and colostomy-free survival [abstract]. Int J Radiat Oncol Biol Phys 2006, 66: S24.
14. Trautmann TG, Zuger JH: Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005, 7: 309-313.
15. Cotter SE, Grigsby PW, Siegel BA, et al.: FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 2006, 65: 720-725.
16. Anderson C, Koshy M, Staley C, et al.: PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 2007, 69: 155-162.
17. Schwarz J, Siegel BA, Dehdashti F, et al.: Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 2007, 71: 180-186.
18. John M, Pajak T, Flam M, et al.: Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 1996, 2: 205-211.
19. Roohipour R, Patil S, Goodman K: Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome. Dis Colon Rectum 2008, 51: 147-153.
20. Glynne-Jones R, Hoskin P: Neoadjuvant cisplatin chemotherapy before chemoradiation: A flawed paradigm. J Clin Oncol 2007, 25: 5281-5286.
21. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al.: Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006, 24: 1057-1063.
22. Brade AM, Tannock IF: Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: Repopulation as a cause of treatment failure? J Clin Oncol 2006, 24: 1020-1022.
23. James R, Meadows H: The second UK phase III anal cancer trial of chemoradiation and maintenance therapy (ACTII): Preliminary results on toxicity and outcome. Proc Am Soc Clin Oncol 2003, 22: 1151.
24. Salama JK, Mell LK, Schomas DA, et al.: Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 2007, 25: 4581-4586.